May 23, 2025
Stat + by Katie Palmer
Stat + reports on the evolving landscape of GLP-1 drug marketing, noting a shift in the relationship between major pharmaceutical companies like Novo Nordisk and telehealth providers. After previously battling telehealth companies offering compounded versions of their drugs, Novo Nordisk is now collaborating with specific telehealth platforms, including Ro and LifeMD. This partnership involves offering branded Wegovy through a mail-order pharmacy at a reduced price and using the telehealth companies to promote limited-time coupons, a marketing strategy experts consider an unusual instance of co-branding between manufacturers and telehealth providers.
Audio Overview (Google NotebookLM)
(6 minutes 24 seconds)
